Back to Arizona
SB1052 • 2026
assisted living; hyperbaric oxygen therapy
SB1052 - assisted living; hyperbaric oxygen therapy
Healthcare
Passed Legislature
This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.
- Sponsor
- Wendy Rogers
- Last action
- 2026-04-16
- Official status
- House committee of the whole
- Effective date
- Not listed
Plain English Breakdown
Checked against official source text during the last sync.
Assisted Living Facilities Can Offer Mild Hyperbaric Oxygen Therapy
This bill allows assisted living facilities to offer mild hyperbaric oxygen therapy (HBOT) under certain conditions and requires informed consent for residents who need directed care services.
What This Bill Does
- Allows assisted living homes and centers to provide mild HBOT using FDA-approved Class II chambers.
- Requires that all HBOT use be ordered by a physician and supervised by trained staff.
- Requires facilities to give residents information about risks and contraindications before starting treatment.
- Prohibits offering HBOT to residents who need directed care services without informed consent from the resident or their authorized representative.
Who It Names or Affects
- Residents of assisted living homes and centers
- Assisted living facilities that provide mild HBOT
Terms To Know
- Mild Hyperbaric Oxygen Therapy (HBOT)
- A medical treatment where a person breathes pure oxygen in a pressurized chamber to help heal tissue and fight infections.
- Directed Care Services
- Services provided by staff for residents who cannot care for themselves without assistance.
Limits and Unknowns
- The bill does not specify the exact effective date.
- It is unclear what specific rules the Department of Health Services will create regarding HBOT use in assisted living facilities.
Amendments
These notes stay tied to the official amendment files and metadata from the legislature.
Plain English: Fifty-seventh Legislature Health & Human Services
Second Regular Session S.B.
- Fifty-seventh Legislature Health & Human Services
Second Regular Session S.B.
- 1052
PROPOSED
HOUSE OF REPRESENTATIVES AMENDMENTS TO S.B.
- 1052
(Reference to Senate engrossed bill)
Strike everything after the enacting clause and insert: 1
"Section 1.
- Repeal 2
Section 41-3026.21, Arizona Revised Statutes, is repealed.
- This amendment summary is using official source text because generated interpretation was skipped for this run.
Bill History
-
2026-04-16
House
House committee of the whole
-
2026-03-31
House
House minority caucus
-
2026-03-31
House
House majority caucus
-
2026-03-30
House
House consent calendar
-
2026-03-04
House
House second read
-
2026-03-03
House
House Rules: C&P
-
2026-03-03
House
House Health & Human Services: DP
-
2026-03-03
House
House first read
-
2026-02-25
House
Transmitted to House
-
2026-02-25
Senate
Senate third read passed
-
2026-02-25
Senate
Senate committee of the whole
-
2026-01-27
Senate
Senate minority caucus
-
2026-01-27
Senate
Senate majority caucus
-
2026-01-26
Senate
Senate consent calendar
-
2026-01-14
Senate
Senate second read
-
2026-01-12
Senate
Senate Rules: PFC
-
2026-01-12
Senate
Senate Health and Human Services: DP
-
2026-01-12
Senate
Senate first read
Official Summary Text
SB1052 - 572R - Senate Fact Sheet
Assigned to
HHS�������������������������������������������������������������������������������������������������������������������� FOR
COMMITTEE
ARIZONA STATE SENATE
Fifty-Seventh
Legislature, Second Regular Session
FACT SHEET FOR
S.B.1052
assisted living; hyperbaric
oxygen therapy
Purpose
Allows assisted living homes and assisted
living centers (assisted living facilities) to offer mild hyperbaric oxygen
therapy (HBOT) to residents and outlines requirements and restrictions on HBOT
use.
Background
HBOT
is a
medical treatment in which an individual is placed in a hyperbaric chamber to
breathe 100 percent pure oxygen. In the chamber, the air pressure is raised to
a level higher than normal air pressure, which helps the lungs collect more
oxygen to heal tissue and fight certain infections.
The U.S. Food and Drug Administration (FDA) currently recognizes HBOT as
an approved treatment for the following medical conditions:
1) air and
gas bubbles in blood vessels;
2) severe anemia; 3) severe and large burns; 4) carbon monoxide poisoning; 5)
crush injury;
6) decompression sickness; 7) gas gangrene
; 8) sudden and complete
hearing loss; 9) infection of the skin and bone; 10) radiation injury; 11)
severe skin grafts 12) sudden and painless vision loss; and 13) non-healing
wounds (
FDA
).
In contrast to traditional HBOT, mild HBOT exposes the user to only 25 to 40
percent oxygen (
NLM
).
Assisted
living facilities
are residential care institutions, including adult foster
care homes, that provide or contract to provide supervisory care services,
personal care services or directed care services on a continuous basis.
Assisted living facilities that provide resident rooms or residential units to 11
or more residents are known as
assisted living centers
, while those
facilities that provide resident rooms or residential units to 10 or fewer
residents are known as
assisted living
homes
(
A.R.S. � 36-401
)
.
There is no
anticipated fiscal impact to the state General Fund associated with this
legislation.
Provisions
1.
Allows
assisted living facilities to offer mild HBOT to residents through a Class II
mild hyperbaric oxygen chamber that:
a)
has received premarket notification
clearance for home use from the FDA;
b)
is
prescribed by or used under the direction of a physician; and
c)
allows
individuals to independently extricate themselves.
2.
Requires assisted living facilities offering HBOT to ensure all HBOT
provided is ordered by a physician and that a staff member who has received
manufacturer-approved training is on-site any time a resident receives HBOT.
3.
Requires assisted living facilities offering HBOT to provide notice to
each resident receiving treatment that:
a)
includes known information about contraindications and risks of HBOT;
b)
recommends consultation with the resident's treating physician about any
personal health risks; and
c)
the device is FDA-approved to treat mild symptoms consistent with acute
mountain sickness and that other use is considered off-label.
4.
Prohibits an assisted living facility from offering HBOT to a resident
requiring directed care services unless the HBOT is ordered by the resident's
treating physician and the resident or an authorized representative provides
informed consent.
5.
Allows the Department of Health Services to adopt any necessary rules
for the purposes of assisted living facility use of HBOT.
6.
Becomes effective on the general effective date.
Prepared by Senate Research
January 14, 2026
MM/MS/hk
Current Bill Text
Read the full stored bill text
SB1052 - 572R - S Ver
Senate Engrossed
assisted living;
hyperbaric oxygen therapy
State of Arizona
Senate
Fifty-seventh Legislature
Second Regular Session
2026
SENATE BILL 1052
AN
ACT
AMending title 36, chapter 4, article 1,
Arizona Revised Statutes, by adding section 36-420.06; relating to health
care institutions.
(TEXT OF BILL BEGINS ON NEXT PAGE)
Be it enacted by the Legislature of the State of Arizona:
Section 1. Title 36, chapter 4, article 1,
Arizona Revised Statutes, is amended by adding section 36-420.06, to read:
START_STATUTE
36-420.06.
Assisted living homes and centers; mild hyperbaric oxygen
therapy; physician orders; notice; informed consent; rules
A. Notwithstanding any other law,
assisted living homes and assisted living centers may
offer
mild hyperbaric oxygen therapy to their residents
through
the use of a class II mild hyperbaric oxygen chamber that has received
premarket notification clearance from the United States food and drug
administration for home use as prescribed by or under the direction of a
physician and from which residents are able to independently extricate
themselves.
B. An assisted living home or
assisted living center that offers mild hyperbaric oxygen therapy to its
residents pursuant to this section shall:
1. Ensure that the use of the mild
hyperbaric oxygen therapy by residents is provided only on the order of a
physician.
2. Ensure that a staff member who has
received training approved by the manufacturer is on-site any time a
resident receives mild hyperbaric oxygen therapy.
3. Provide a notice to each resident
who receives mild hyperbaric oxygen therapy that the United States food and
drug administration has approved the device to treat mild symptoms consistent
with acute mountain sickness and that any other use is considered off-label.�
The notice shall provide known information about contraindications and risks of
using the device and recommend that the resident consult the resident's
treating physician about any personal health risks.
C. An assisted living home or
assisted living center may not offer mild hyperbaric oxygen therapy to a
resident who requires directed care services unless the therapy is provided on
the order of the resident's treating physician and the resident or the
resident's authorized representative provides informed consent.
D. The department may adopt any
necessary rules for the purposes of this section.
END_STATUTE